Development of a V79 cell line expressing human cytochrome P450 2D6 and its application as a metabolic screening tool

Author： Rauschenbach R.   Gieschen H.   Salomon B.   Kraus C.   Kuhne G.   Hildebrand M.  

Publisher： Elsevier

ISSN： 1382-6689

Source： Environmental Toxicology and Pharmacology, Vol.3, Iss.1, 1997-02, pp. : 31-39

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pharmacophore, QSAR, and Binding Mode Studies of Substrates of Human Cytochrome P450 2D6 (CYP2D6) Using Molecular Docking and Virtual Mutations and an Application to Chinese Herbal Medicine Screening

By  

Current Pharmaceutical Biotechnology, Vol. 13, Iss. 9, 2012-07 ,pp. : 1640-1704

Bentham Science Publishers

Access to resources Recommend Favorite

Polymorphism of Human Cytochrome P450 2D6 and Its Clinical Significance: Part II

By Zhou Shu-Feng  

Clinical Pharmacokinetics, Vol. 48, Iss. 12, 2009-12 ,pp. : 761-804

Adis International

Access to resources Recommend Favorite

Polymorphism of Human Cytochrome P450 2D6 and Its Clinical Significance: Part I

By Zhou Shu-Feng  

Clinical Pharmacokinetics, Vol. 48, Iss. 11, 2009-11 ,pp. : 689-723

Adis International

Access to resources Recommend Favorite

Substrate Specificity, Inhibitors and Regulation of Human Cytochrome P450 2D6 and Implications in Drug Development

By  

Current Medicinal Chemistry, Vol. 16, Iss. 21, 2009-07 ,pp. : 2661-2805

Bentham Science Publishers

Access to resources Recommend Favorite

Contribution of Cytochrome P450 2D6 to 3,4-Methylenedioxymethamphetamine Disposition in Humans: Use of Paroxetine as a Metabolic Inhibitor Probe

By Segura Mireia   Farré Magí   Pichini Simona  

Clinical Pharmacokinetics, Vol. 44, Iss. 6, 2005-01 ,pp. : 649-660

Adis International

Access to resources Recommend Favorite